OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
13
Results
Show all
Save search
Copy query
Show results for
Unknown
(13)
Publication Date
Release Date
2025
(3)
2022
(3)
2023
(2)
2014
(2)
2024
(1)
2021
(1)
2010
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An Update.
Not available
S-EPMC9697413
|
biostudies-literature
Cite
Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice.
Not available
S-EPMC2909229
|
biostudies-literature
Cite
The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma.
Not available
S-EPMC10217181
|
biostudies-literature
Cite
Immune-Based Combinations versus Sorafenib as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Meta-Analysis.
Not available
S-EPMC9858216
|
biostudies-literature
Cite
Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine.
Not available
S-EPMC9396390
|
biostudies-literature
Cite
Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trial.
Not available
S-EPMC12242418
|
biostudies-literature
Cite
Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial.
Not available
S-EPMC11964631
|
biostudies-literature
Cite
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study.
Not available
S-EPMC11511690
|
biostudies-literature
Cite
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid.
Not available
S-EPMC9804305
|
biostudies-literature
Cite
Real-world experience with obeticholic acid in patients with primary biliary cholangitis.
Not available
S-EPMC7930359
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets